Real-time detection of PML-RARA and RARA-PML fusion transcripts in high risk acute promyelocytic leukemia (APL) treated with arsenic trioxide (ATO): Implications for realization of pre-emptive therapy for molecular relapse.

Grimwade, David, Jovanovic, J. V., Diverio, D, Nugent, E, Ho, A. Y., Mufti, G. J., Hills, Robert Kerrin

, Solomon, E., Clark, R. E., Lo Coco, F. and Burnett, Alan K. 2006. Real-time detection of PML-RARA and RARA-PML fusion transcripts in high risk acute promyelocytic leukemia (APL) treated with arsenic trioxide (ATO): Implications for realization of pre-emptive therapy for molecular relapse. Blood -New York- 108 (11) , 149A-150A.

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Subjects:	R Medicine > R Medicine (General) R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology
Additional Information:	48th Annual Meeting of the American-Society-of-Hematology Location: Orlando, FL Date: DEC 09-12, 2006
Publisher:	American Society of Hematology
ISSN:	0006-4971
Last Modified:	24 Oct 2022 11:55
URI:	https://orca.cardiff.ac.uk/id/eprint/49732

Actions (repository staff only)

Edit Item

CORE (COnnecting REpositories)